FULC
Fulcrum Therapeutics, Inc. · Healthcare
Director Robert J Gould sold $533K of Fulcrum Therapeutics, Inc.
Sold$532,810
$8.00Price
66,622Shares
−12%Stake
What FULC did after the filing
- The stock from Mon, Jun 6 close, $7.53
- −21.4%
- S&P 500, same days
- −3.7%
Measured over 30 trading days, to the Jul 20 close.
Traded Thu, Jun 2. Filed Mon, Jun 6, 3:00 PM ET, during the session. Returns use the Jun 6 close and the Jul 20 close. Not investment advice.